Rovi, ES0157261019

Rovi stock pre-market: EUR 58.63, prior close EUR 58.50

Published on 10/09/2026 at 07:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Rovi stock was EUR 58.63 pre-market at Lang & Schwarz on October 9, 2026, up 0.22 percent. Nine-month 2026 results are scheduled for November 5, 2026.

Key points in brief

  • Rovi stock was EUR 58.63 pre-market at Lang & Schwarz on October 9, 2026.
  • The price was up 0.22 percent versus the October 8 prior close.
  • Rovi's investor calendar lists nine-month 2026 results for November 5, 2026.
Rovi, ES0157261019, Illustration mit AI erstellt.
Rovi, ES0157261019, Illustration mit AI erstellt.

Rovi stock was EUR 58.63 pre-market at Lang & Schwarz at 7:30 a.m. CEST on October 9, 2026, up 0.22 percent versus the prior close at Lang & Schwarz of EUR 58.50 on October 8, 2026. The bid was EUR 58.45 and the ask was EUR 58.80. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Rovi stock.

What matters today

Laboratorios Farmacéuticos ROVI, S.A. lists its first nine months 2026 financial results for November 5, 2026, on its investor-relations calendar. Rovi's 52-week high is EUR 85.65, which is 46.09 percent above the pre-market price, according to Simply Wall St. The same page, updated one day before October 9, 2026, lists a trailing dividend yield of 1.70 percent.

Rovi's investor calendar identifies the November 5 release as the next scheduled financial event and describes it as the first nine months 2026 financial results. The company is Laboratorios Farmacéuticos ROVI, S.A., whose investor-relations page also identifies the company by that legal name.

Market context: Market report IBEX 35.

More news and analysis on Rovi stock

Disclaimer...

en | ES0157261019 | ROVI | boerse | 70271962 | bgmi